EUVIMEDEUVIMED entdecken
Crossref

Cord Blood Cell-Free DNA Concentration: A Novel Marker for Neonatal Wellbeing

Majdi Imterat iD, Offer Erez, Dan Tirosh, Yael Miller Gelkop, Neta Benshalom-Tirosh, Maor Ben-Tabo, Amos Douvdevani

American Journal of Perinatology · 01.06.2024 · 41 (08) · 1027-1032

DOI: 10.1055/a-1787-3838 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.06.2024. Verfasst von Majdi Imterat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Bee…. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, Fetal Blood, Biomarkers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Cord gas values and Apgar scores, currently used as markers for newborn wellbeing and postpartum complications, provide rough estimates, and their use remains elusive. Circulating cell-free DNA (cfDNA) may better represent newborn status at birth and the effect of parturition on the fetus. This pilot study investigates the association between cord blood (CB) cfDNA and neonatal outcomes. Study Design In a prospective cohort study, cfDNA concentration was measured in immediately following delivery collected CB sera of newborns using our rapid fluorescent assay.

Results

During the study period, blood samples from umbilical cords of 100 newborns were collected. Vaginal delivery was associated with a higher median CB cfDNA than cesarean delivery (277 [95% confidence interval [CI] 199–377] vs. 100 [95% CI 43–265] ng/mL, p < 0.01). cfDNA levels were significantly associated with gestational age at delivery (rho = 0.308, p = 0.002) and CB base deficit (BD, r = 0.252, p = 0.017). According to maternal and fetal complications, CB cfDNA was elevated in fetuses with category II of heart rate tracing (p < 0.05), with maternal positive vaginal culture (p < 0.01), and with premature rupture of membranes (PROM, p < 0.001). Logistic regression models of CB cfDNA fourth quartiles demostrate a double odds ratio for elevated BD (>3mmol/L) and for worse heart rate tracing category.

Conclusion

Serum CB cfDNA concentration reflects the newborn's status and hazards with an excellent association with CB BD, fetal heart rate category, and maternal risk factors for infection (positive vaginal culture and PROM). This preliminary observation suggests that cfDNA can serve as a point of care biomarker for newborn status at the time of delivery. Key Points

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell-Free Nucleic AcidsFetal BloodBiomarkersHumansFemaleInfant, NewbornPilot ProjectsProspective StudiesPregnancyAdultMaleGestational AgeDelivery, ObstetricCesarean SectionLogistic ModelsApgar Score

Substanzen

Cell-Free Nucleic AcidsBiomarkers

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany.
  • Department of Obstetrics and Gynecology, HaEmek Medical Center, Afula, Israel.
  • Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, Michigan.
  • Department of Life Sciences, Faculty of Natural Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Department of Clinical Biochemistry and Pharmacology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

ORCID-Profile: Majdi Imterat

Zitieren

APA

Imterat, M., Erez, O., Tirosh, D., Gelkop, Y. M., Benshalom-Tirosh, N., Ben-Tabo, M., & Douvdevani, A. (2024). Cord Blood Cell-Free DNA Concentration: A Novel Marker for Neonatal Wellbeing. American Journal of Perinatology, 41(08), 1027-1032. https://doi.org/10.1055/a-1787-3838

Vancouver

Imterat M, Erez O, Tirosh D, Gelkop YM, Benshalom-Tirosh N, Ben-Tabo M, et al. Cord Blood Cell-Free DNA Concentration: A Novel Marker for Neonatal Wellbeing. American Journal of Perinatology. 2024;41(08):1027-1032. doi:10.1055/a-1787-3838

BibTeX
@article{Imterat2024,
  author = {Imterat, Majdi and Erez, Offer and Tirosh, Dan and Gelkop, Yael Miller and Benshalom-Tirosh, Neta and Ben-Tabo, Maor and Douvdevani, Amos},
  title = {Cord Blood Cell-Free DNA Concentration: A Novel Marker for Neonatal Wellbeing},
  journal = {American Journal of Perinatology},
  year = {2024},
  volume = {41},
  number = {08},
  pages = {1027--1032},
  doi = {10.1055/a-1787-3838}
}
Kostenlos starten →